Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Haberer, Jessica E ^a,b   Kiwanuka, Julius ^c   Nansera, Denis ^c   Ragland, Kathleen ^a   Mellins, Claude ^d   Bangsberg, David R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; VIRUS RNA;

ALCOHOL CONSUMPTION; ARTICLE; CAREGIVER; CAREGIVER BURDEN; CHILD; DRUG EFFICACY; DRUG FORMULATION; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; UGANDA; BLOOD; CLINICAL TRIAL; HUMAN IMMUNODEFICIENCY VIRUS 1; MULTICENTER STUDY; PRESCHOOL CHILD; TIME;

ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HIV-1; HOSPITALIZATION; HUMANS; MALE; MEDICATION ADHERENCE; RNA, VIRAL; TIME FACTORS; UGANDA;

EID: 84860769449     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036737     Document Type: Article

References (46)

1. UNAIDS Report on the Global AIDS Epidemic (2010) 12 Available: http://issuu.com/unaids/docs/unaids_globalreport_2010. Accessed 2011 Oct.
2. Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM, (2008) A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J 27: 686-691.
3. Cupsa A, Gheonea C, Bulucea D, Dinescu S, (2000) Factors with a negative influence on compliance to antiretroviral therapies. Ann N Y Acad Sci 918: 351-354.
4. Fassinou P, Elenga N, Rouet F, Laguide R, Kouakoussui KA, et al. (2004) Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS 18: 1905-1913.
5. Haberer JE, Cook A, Walker AS, Ngambi M, Ferrier A, et al. (2011) Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One 6: e18505.
6. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, et al. (2006) Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 10: S85-93.
7. Muller AD, Bode S, Myer L, Stahl J, von Steinbuchel N, (2008) Predictors of adherence to antiretroviral treatment and therapeutic success among children in South Africa. AIDS Care 23: 129-138.
8. Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, Byakika-Tusiime J, Musoke P, (2007) Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala. Ann Trop Paediatr 27: 123-131.
9. da Silveira VL, Drachler Mde L, Leite JC, Pinheiro CA, (2003) Characteristics of HIV antiretroviral regimen and treatment adherence. Braz J Infect Dis 7: 194-201.
10. Nyandiko WM, Ayaya S, Nabakwe E, Tenge C, Sidle JE, et al. (2006) Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr 43: 418-425.
11. Rongkavilit C, Naar-King S, Kaljee LM, Panthong A, Koken JA, et al. (2007) Applying the information-motivation-behavioral skills model in medication adherence among Thai youth living with HIV: a qualitative study. AIDS Patient Care STDS 24: 787-794.
12. Safreed-Harmon K, Siripong A, Kerr SJ, Gruskin S, Pancharoen C, et al. (2007) Antiretroviral therapy adherence did not differ between Thai children with biological and those with nonbiological parents. Clin Infect Dis 45: 669-670.
13. Eley B, Nuttall J, Davies MA, Smith L, Cowburn C, et al. (2004) Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents. S Afr Med J 94: 643-646.
14. Evans-Gilbert T, Pierre R, Steel-Duncan JC, Rodriguez B, Whorms S, et al. (2004) Antiretroviral drug therapy in HIV-infected Jamaican children. West Indian Med J 53: 322-326.
15. Bunupuradah T, Wannachai S, Chuamchaitrakool A, Intasan J, Nuchapong T, et al. (2006) Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals. AIDS Res Ther 3: 30.
16. Myung P, Pugatch D, Brady MF, Many P, Harwell JI, et al. (2007) Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia. Am J Public Health 97: 974-977.
17. Muller AD, Bode S, Myer L, Roux P, von Steinbuchel N, (2008) Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa. Pediatr Infect Dis J 27: 257-262.
18. Haberer J, Mellins C, (2009) Pediatric adherence to HIV antiretroviral therapy. Curr HIV/AIDS Rep 6: 194-200.
19. National Paediatric ART Guidelines, 2nd edition, (2008) Uganda Ministry of Health. 18 Available: http://www.who.int/hiv/amds/uganda_moh_treatment_ guidelines.pdf. Accessed 2012 Apr.
20. Fatti G, Bock P, Eley B, Mothibi E, Grimwood A, (2011) Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009. J Acquir Immune Defic Syndr 58: e60-67.
21. Sutcliffe CG, Bolton-Moore C, van Dijk JH, Cotham M, Tambatamba B, et al. (2010) Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study. BMC Pediatr 10: 54.
22. Walsh JC, Mandalia S, Gazzard BG, (2002) Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 16: 269-277.
23. Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, et al. (2008) Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One 3: e2783.
24. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, et al. (2007) Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 21: 965-971.
25. Bolton P, (2001) Cross-cultural validity and reliability testing of a standard psychiatric assessment instrument without a gold standard. J Nerv Ment Dis 189: 238-242.
26. Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, et al. (1995) A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med 332: 693-699.
27. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA, (1997) Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res 6: 531-554.
28. Pediatric AIDS Clinical Trials Group. Pediatric Adherence Questionnaire, Modules 1 & 2. 22 Available at: https://www.fstrf.org/apps/cfmx/apps/common/QOLAdherenceForms/index.cfm?project=IMPAACT. Accessed 2012 Feb.
29. Filmer D, Pritchett LH, (2001) Estimating wealth effects without expenditure data- or tears: an application to educational enrollments in states of India. Demography 38: 115-132.
30. Bangsberg DR, (2006) Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 43: 939-941.
31. Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, et al. (2001) Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA 286: 171-179.
32. Marhefka SL, Koenig LJ, Allison S, Bachanas P, Bulterys M, et al. (2008) Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care STDS 22: 637-647.
33. Drotar D, Bonner MS, (2009) Influences on adherence to pediatric asthma treatment: a review of correlates and predictors. J Dev Behav Pediatr 30: 574-582.
34. Fiese BH, Wamboldt FS, Anbar RD, (2005) Family asthma management routines: connections to medical adherence and quality of life. J Pediatr 146: 171-176.
35. Bangsberg DR, Ragland K, Monk A, Deeks SG, (2010) A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS 24: 2835-2840.
36. Llibre JM, Arribas JR, Domingo P, Gatell JM, Lozano F, et al. (2011) Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy. AIDS 25: 1683-1690.
37. Jaspan HB, Mueller AD, Myer L, Bekker LG, Orrell C, (2011) Effect of Caregivers' Depression and Alcohol Use on Child Antiretroviral Adherence in South Africa. AIDS Patient Care STDS.
38. Hahn JA, Woolf-King SE, Muyindike W, (2011) Adding Fuel to the Fire: Alcohol's Effect on the HIV Epidemic in Sub-Saharan Africa. Curr HIV/AIDS Rep 8: 172-180.
39. Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, et al. (2009) Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav 13 (Suppl 1): 82-91.
40. Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K, (2008) Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health 8: 265.
41. Remien RH, Mellins CA, (2007) Long-term psychosocial challenges for people living with HIV: let's not forget the individual in our global response to the pandemic. AIDS 21 (Suppl 5): S55-63.
42. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, et al. (2006) Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav 10: 227-245.
43. Muller AD, Jaspan HB, Myer L, Hunter AL, Harling G, et al. (2010) Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting. AIDS Behav 15: 422-431.
44. Bussmann H, de la Hoz Gomez F, Roels TH, Wester CW, Bodika SM, et al. (2010) Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey. AIDS Res Hum Retroviruses 27: 365-372.
45. Haberer JE, Kahane J, Kigozi I, Emenyonu N, Hunt P, et al. (2010) Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav 14: 1340-1346.
46. Deschamps AE, Van Wijngaerden E, Denhaerynck K, De Geest S, Vandamme AM, (2006) Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr 43: 247-248.